Kither Biotech
Manufacturing · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Via Nizza 52, Torino, Emilia-Romagna, It...Phone Number
+39 116706425Website
www.kitherbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Kither Biotech
Kither Biotech is a biopharma company founded by Prof. Alessandra Ghigo, Prof. Emilio Hirsch, Prof. Alberto Bardelli and Marco Kevin Malisani. The company aims to identify and develop new drug candidates for the treatment of rare pulmonary diseases, with specific focus on cystic fibrosis and idiopathic pulmonary fibrosis. Kither Biotech is a spin-off from the University of Turin and actively collaborates with the Molecular Biotechnology Center (University of Turin) and other research centres in the world.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kither Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Kither Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Kither Biotech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Kither Biotech
Earning: See what the market has to say on Kither Biotech recently announced quarterly report
Funding: Get notified immidiatlly once Kither Biotech has new funding data
Kither Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Kither Biotech is spiking on competitors!
Check if Kither Biotech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Kither Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kither Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kither Biotech.
Kither Biotech financials insights
Gather financial insights about Kither Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$6.2M
2022
Series B
$20.3M
Kither Biotech Tech Stack
A closer look at the technologies used by Kither Biotech
Kither Biotech News & Media
KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR CYSTIC FIBROSIS
Study to evaluate the safety and tolerability of KIT2014, an inhaled peptide therapy designed to enhance Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function, act as a bronchodilator, and reduce inflammation KIT2014 is being developed as a CFTR enhancer, acting as an add-on...Kither Biotech announces publication of new data in Science Translational Medicine
Kither Biotech announces publication of new data in Science Translational MedicineKither Biotech Raises €18.5M in Series B Funding
Kither Biotech, a Turin, Italy-based biopharmaceutical company developing novel therapies for rare respiratory diseases, raised €18.5m in Series B financing round. The round was co-led by new investors Claris Ventures and 2 Invest, with participation from 3B Future Health Fund and Alef 6 and existing investors CDP Venture Capital SGR, Italian Angels for Growth, Ersel, […] The post Kither Biotech Raises €18.5M in Series B Funding appeared first on FinSMEs.Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer Proceeds to support the further development of lead asset KIT2014 in cystic fibrosis through to Phase 1/2A clinical trial International syndicate of new investors including Claris Ventures, 2 Invest, 3B Future Health Fund and Alef 6, with continued support from existing investorsAppointment of Dr. Metzler as CEO brings extensive international pharmaceutical experience as Kither Biotech accele
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Kither Biotech
Sign Up For FreeTo access detailed company insights
Kither Biotech is a biopharma company founded by Prof. Alessandra Ghigo, Prof. Emilio Hirsch, Prof. Alberto Bardelli and Marco Kevin Malisani. The company aims to identify and develop new drug candidates for the treatment of rare pulmonary diseases, with specific focus on cystic fibrosis and idiopathic pulmonary fibrosis. Kither Biotech is a spin-o... Read More
